MedTrace Logo

A Retrospective Breast Reconstruction Study

NCT04060134 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 223

Last updated 2024-02-14

No results posted yet for this study

Summary

To collect data on patients who have previously undergone breast reconstruction utilizing SimpliDerm and other HADMs.

Conditions

Interventions

OTHER

SimpliDerm HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

AlloDerm HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

AlloMax HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

FlexHD HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

DermACELL HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

Sponsors & Collaborators

  • Elutia Inc.

    lead INDUSTRY

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-20
Primary Completion
2022-03-14
Completion
2022-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04060134 on ClinicalTrials.gov